|
Volumn 503, Issue 2-3, 2001, Pages 206-212
|
Proteasome inhibitors and immunosuppressive drugs promote the cleavage of eIF4GI and eIF4GII by caspase-8-independent mechanisms in Jurkat T cell lines
|
Author keywords
Apoptosis; Caspase 8; Cyclosporin A; eIF4G; FTY720; MG132
|
Indexed keywords
BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL;
CASPASE 3;
CASPASE 8;
CYCLOSPORIN A;
FAS ANTIBODY;
FINGOLIMOD;
IMMUNOSUPPRESSIVE AGENT;
INITIATION FACTOR 4E;
INITIATION FACTOR 4G;
INITIATION FACTOR 4GI;
INITIATION FACTOR 4GII;
LACTACYSTIN;
PEPTIDE FRAGMENT;
PROTEASOME INHIBITOR;
RECOMBINANT ANTIBODY;
UNCLASSIFIED DRUG;
ANTIBODY SPECIFICITY;
APOPTOSIS;
ARTICLE;
CELL VIABILITY;
CONTROLLED STUDY;
DRUG EFFECT;
ENZYME ACTIVATION;
HUMAN;
HUMAN CELL;
LEUKEMIA CELL LINE;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
ACETYLCYSTEINE;
ANTIGENS, CD95;
APOPTOSIS;
CALPAIN;
CASPASE 8;
CASPASE 9;
CASPASES;
CYCLOSPORINE;
CYSTEINE ENDOPEPTIDASES;
CYSTEINE PROTEINASE INHIBITORS;
EUKARYOTIC INITIATION FACTOR-4G;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
JURKAT CELLS;
LEUPEPTINS;
MULTIENZYME COMPLEXES;
PEPTIDE FRAGMENTS;
PEPTIDE INITIATION FACTORS;
PROPYLENE GLYCOLS;
PROTEASOME ENDOPEPTIDASE COMPLEX;
SPHINGOSINE;
T-LYMPHOCYTES;
|
EID: 0035902916
PISSN: 00145793
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-5793(01)02735-1 Document Type: Article |
Times cited : (10)
|
References (56)
|